Ahmadi, BahramNaeimi, BehrouzAhmadipour, Mohammad JavadMorovati, Hamidde Groot, TheunSpruijtenburg, BramBadali, HamidMeis, Jacques F.2024-06-282024-06-282023-11-11Journal of Fungi 9 (11): 1101 (2023)https://hdl.handle.net/20.500.12588/6446<i>Candida auris</i> is a newly emerging multidrug-resistant fungal pathogen considered to be a serious global health threat. Due to diagnostic challenges, there is no precise estimate for the prevalence rate of this pathogen in Iran. Since 2019, only six culture-proven <i>C. auris</i> cases have been reported from Iran, of which, five belonged to clade V and one to clade I. Herein, we report a case of otomycosis due to <i>C. auris</i> from 2017 in a 78-year-old man with diabetes mellitus type II without an epidemiological link to other cases or travel history. Short tandem repeat genotyping and whole genome sequencing (WGS) analysis revealed that this isolate belonged to clade I of <i>C. auris</i> (South Asian Clade). The WGS single nucleotide polymorphism calling demonstrated that the <i>C. auris</i> isolate from 2017 is not related to a previously reported clade I isolate from Iran. The presence of this retrospectively recognized clade I isolate also suggests an early introduction from other regions or an autochthonous presence. Although the majority of reported <i>C. auris</i> isolates worldwide are resistant to fluconazole and, to a lesser extent, to echinocandins and amphotericin B, the reported clade I isolate from Iran was susceptible to all antifungal drugs.2024-06-28